Back to today’s briefing

Story perspectives

Breakthrough Blood Test Detects Pancreatic Cancer Early

12/16/2025

37 3

Summary

Story summary

Oregon Health & Science University researchers have developed a blood-based liquid biopsy for early pancreatic cancer detection, identifying 73% of patients and distinguishing healthy individuals with 98% accuracy.
The test targets the lack of approved pancreatic cancer screening tests, a disease with a low five-year survival rate.
The FDA has approved few liquid biopsies, raising concerns about accessibility and insurance coverage.

1 of 1

Story summary

Oregon Health & Science University researchers have developed a blood-based liquid biopsy for early pancreatic cancer detection, identifying 73% of patients and distinguishing healthy individuals with 98% accuracy.
The test targets the lack of approved pancreatic cancer screening tests, a disease with a low five-year survival rate.
The FDA has approved few liquid biopsies, raising concerns about accessibility and insurance coverage.